Nanomedicine News- Health and wellness in the community is the theme of this year's UBThisSummer ... - University at Buffalo Reporter - May 17, 2012
- NanoViricides Appoints Mr. Andrew Hahn as Consultant for Design and ... - EON: Enhanced Online News (press release) - May 15, 2012
- New Summer Research School in nanomedicine at Karolinska - Science Business - May 10, 2012
- Arrowhead Reports Fiscal 2012 Second Quarter Financial Results - TheStreet.com (press release) - May 9, 2012
- Arrowhead Reports Fiscal 2012 Second Quarter Financial Results - MarketWatch (press release) - May 8, 2012
- NanoViricides Announces Issuance of a Fundamental Patent in the USA - EON: Enhanced Online News (press release) - May 7, 2012
- MagForce to Present at Entry & General Standard Conference 2012 in Frankfurt - Reuters - May 7, 2012
- Midatech and MonoSol Rx Announce Positive Phase 1 Clinical Results for Their ... - MarketWatch (press release) - May 3, 2012
- Cooperative dual-activity targeted nanomedicine for specific and effective ... - UroToday - April 25, 2012
- Nanotechnology and Medicine - dailyRx - April 25, 2012
Tag Archives: cancer
Nanotechnology for Targeted Cancer Therapy
A short animation outlining the fundamentals of targeted nanomedicine for cancer therapy, one of our group’s primary research focuses. For more information, see nanomedicine.uwaterloo.ca © 2010 University of Waterloo Frank Gu Research Group Waterloo Institute for Nanotechnology Department of Chemical … Continue reading
TEDxCaltech – Mark E. Davis – Nanomedicines: Nanobiotech v. Cancer
Mark E. Davis is the Warren and Katharine Schlinger Professor of Chemical Engineering at Caltech and a member of the Experimental Therapeutics Program of the Comprehensive Cancer Center at the City of Hope. He has over 350 scientific publications, two … Continue reading
Posted in Nanomedicine News
Tagged cancer, Davis, Mark, Nanobiotech, Nanomedicines, TEDxCaltech
Comments Off